Glenn Saldanha Board of Director Membership

Home

Insights

Glenn Saldanha Board Membership

Last Updated on: Nov 12, 2024

About Glenn Saldanha

Glenn Saldanha joined Glenmark Pharmaceuticals in 1998 and became the Managing Director & CEO in 2000.
Under his leadership, he transformed Glenmark from an Indian branded generics company into a multinational organization with revenues exceeding USD 1.5 billion.
He is dedicated to the vision of discovering and developing India’s first innovative drug for global markets, steering the company towards a research-driven and innovation-led future.
Saldanha has played a crucial role in establishing Glenmark as a prominent player in the pharmaceutical industry, recognized for its achievements, including winning the ‘Indian Pharma Innovation of the Year’ award for two consecutive years from the Government of India.

List of Companies Associated with Glenn Saldanha

Company Name	Position Held	Market Cap	Sector	Date Of Appointment

Glenmark Pharmaceuticals Ltd

Chairman & Managing Director

47032.3

Pharmaceuticals

Mar, 2015

Company Name	Position Held
Glenmark Pharmaceuticals Ltd	Chairman & Managing Director

PRICE

<p>The current market price or CMP refers to the price of those companies associated with Glenn Saldanha at which the securities are trading in the share market.</p> <br> <h2>Current price in Over-the-counter costs:</h2> <p>The following current price of those companies associated with Glenn Saldanha depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC).</p> <br> <h2>Current Price in Bond Market: </h2> <p>The current price of a bond of those companies associated with Glenn Saldanha is determined by measuring the actual interest rate against the bid-related interest rate.</p> <br> <p>The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.</p>

Historical Share prices

* All values are in Rupees

Glenn Saldanha Sector Specific Experience

About Glenn Saldanha's work experience

Glenn Saldanha is currently a Chairman & Managing Director in Glenmark Pharmaceuticals Ltd (as of Mar 2024).
Glenn Saldanha is serving the company - Glenmark Pharmaceuticals Ltd at this position since 2015 for the last 10+ years.
Prior to becoming Chairman & Managing Director, Glenn Saldanha was Chairman & Non Executive Dir. of Glenmark Life Sciences Ltd for 3 years from 2021 to 2023.
Before becoming Chairman & Non Executive Dir., Glenn Saldanha was Chairman / Executive Director / M D / Promoter of Glenmark Pharmaceuticals Ltd for 1 year in 2023.

FAQ's related Glenn Saldanha

Who is Glenn Saldanha

Glenn Saldanha joined Glenmark Pharmaceuticals in 1998 and became the Managing Director & CEO in 2000. Under his leadership, he transformed Glenmark from an Indian branded generics company into a multinational organization with revenues exceeding USD 1.5 billion. He is dedicated to the vision of discovering and developing India’s first innovative drug for global markets, steering the company towards a research-driven and innovation-led future. Saldanha has played a crucial role in establishing Glenmark as a prominent player in the pharmaceutical industry, recognized for its achievements, including winning the ‘Indian Pharma Innovation of the Year’ award for two consecutive years from the Government of India.

Which companies does Glenn Saldanha serve as a board member for?

Glenn Saldanha serves as a board member for: Glenmark Pharmaceuticals Ltd,Glenmark Life Sciences Ltd

What positions has Glenn Saldanha held in his/her career?

Throughout their career, Glenn Saldanha has held key positions such as Chairman & Managing Director,Chairman & Non Executive Dir.,Chairman / Executive Director / M D / Promoter, contributing to the growth and success of each company.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.

Unlimited trading at just

~~Rs. 399~~

Rs. 199*